EGR1 and neoplasm: The tumor tissues of nude mice co-treated with knockdown EGR1 and gemcitabine showed decreased tumor volume, decreased body weight, and lower proliferation capacity than the sh-NC group, enhancing the inhibitory effect of gemcitabine on tumor growth (Fig. 4B and C).